Abstract
Phenotypic heterogeneity of glioblastomas is a leading determinant of therapeutic resistance and treatment failure. However, functional assessment of the heterogeneity of glioblastomas is lacking. We developed a self-assembly-based assessment system that predicts inter/intracellular heterogeneity and phenotype associations, such as cell proliferation, invasiveness, drug responses, and gene expression profiles. Under physical constraints for cellular interactions, mixed populations of glioblastoma cells are sorted to form a segregated architecture, depending on their preference for binding to cells of the same phenotype. Cells distributed at the periphery exhibit a reduced temozolomide (TMZ) response and are associated with poor patient survival, whereas cells in the core of the aggregates exhibit a significant response to TMZ. Our results suggest that the multicellular self-assembly pattern is indicative of the intertumoral and intra-patient heterogeneity of glioblastomas, and is predictive of the therapeutic response.
Funder
National Research Foundation of Korea
Korea Health Industry Development Institute
Reference30 articles.
1. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma;Patel;Science,2014
2. Tumour heterogeneity and resistance to cancer therapies;Shaw;Nat. Rev. Clin. Oncol.,2018
3. Overcoming therapeutic resistance in glioblastoma: The way forward;Osuka;J. Clin. Investig.,2017
4. The WHO Classification of Tumours of the Central Nervous System, 4th edition;Fuller;Arch. Pathol. Lab. Med.,2008
5. Liesche-Starnecker, F., Mayer, K., Kofler, F., Baur, S., Schmidt-Graf, F., Kempter, J., Prokop, G., Pfarr, N., Wei, W., and Gempt, J. (2020). Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma. Cancers, 12.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献